AMGN

Amgen
D

AMGN

Arincen67/100B

Amgen cash on hand 1988–2026

Amgen had 13.19B USD in cash and short-term investments on 30 September 2026, up 39.7% on a year before. At the end of fiscal year 2025 it had 9.13B USD.

Last updated 12 Nov 2026 · Next report 2 Feb 2027

Cash on hand

Growth

Fiscal yearPeriod endingCash on handGrowthTotal debtNet cash
Latest quarter30 Sept 202613.19B+39.65%54.01B-40.82B
FY202531 Dec 20259.13B-23.75%54.60B-45.48B
FY202431 Dec 202411.97B+9.40%60.10B-48.13B
FY202331 Dec 202310.94B+17.61%64.61B-53.67B
FY202231 Dec 20229.31B+15.78%38.95B-29.64B
FY202131 Dec 20218.04B-24.51%33.31B-25.27B
FY202031 Dec 202010.65B+19.48%32.99B-22.34B
FY201931 Dec 20198.91B-69.59%29.90B-20.99B
FY201831 Dec 201829.30B-29.69%33.93B-4.63B
FY201731 Dec 201741.68B+9.43%35.34B6.34B
FY201631 Dec 201638.09B+21.36%34.60B3.49B
FY201531 Dec 201531.38B+16.12%31.43B-47.00M
FY201431 Dec 201427.03B+39.30%30.72B-3.69B
FY201331 Dec 201319.40B-19.37%32.13B-12.73B
FY201231 Dec 201224.06B+16.57%26.53B-2.47B
FY201131 Dec 201120.64B+18.48%21.43B-787.00M
FY201031 Dec 201017.42B+29.61%13.36B4.06B
FY200931 Dec 200913.44B+40.72%10.60B2.84B
FY200831 Dec 20089.55B+33.58%10.18B-624.00M
FY200731 Dec 20077.15B+13.92%11.18B-4.03B
FY200631 Dec 20066.28B+19.45%9.01B-2.74B
FY200531 Dec 20055.26B-9.52%3.96B1.30B
FY200431 Dec 20045.81B+13.37%5.11B698.00M
FY200331 Dec 20035.12B+9.84%3.08B2.04B
FY200231 Dec 20024.66B+75.19%3.17B1.49B
FY200131 Dec 20012.66B+31.27%322.90M2.34B
FY200031 Dec 20002.03B+52.15%322.70M1.71B
FY199931 Dec 19991.33B+562.85%322.50M1.01B
FY199831 Dec 1998201.10M-15.89%328.70M-127.60M
FY199731 Dec 1997239.10M+41.23%259.00M-19.90M
FY199631 Dec 1996169.30M+153.82%177.20M-7.90M
FY199531 Dec 199566.70M-68.43%246.90M-180.20M
FY199431 Dec 1994211.30M+64.44%283.10M-71.80M
FY199331 Dec 1993128.50M+39.67%291.00M-162.50M
FY199231 Dec 199292.00M-37.20%131.90M-39.90M
FY199131 Dec 1991146.50M+310.36%41.50M105.00M
FY199031 Dec 199035.70M+72.46%14.50M21.20M
FY198831 Dec 198820.70M—32.20M-11.50M

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Total debt,Free cash flow,Stock buybacks,Balance sheet

Common questions about Amgen's cash

Source: Financial Modeling PrepVerified against SEC filings